Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-11-14Clinical Trial Update: Double-Blind Trial of a Probiotic Supplement to Reduce the Symptoms of Schizophrenia [NA]
A double-blind trial tested a probiotic supplement for reducing symptoms in schizophrenia and schizoaffective disorder; results were posted …
-
CLINICAL_TRIALS trial_result · 2013-11-12Clinical Trial Update: A Trial Comparing Risperidone Long-Acting Injection With Oral Antipsychotic in the Treatment of Early Psychosis [Phase 4]
A Phase 4 trial compared risperidone long-acting injection with an oral antipsychotic in early psychosis; results were posted in 2013 and in…
-
CLINICAL_TRIALS trial_result · 2013-11-11Clinical Trial Update: Broad Effectiveness: Study With Aripiprazole [Phase 3]
Phase 3 study evaluating aripiprazole investigates overall effectiveness in schizophrenia and schizoaffective disorder; the trial status is …
-
CLINICAL_TRIALS trial_result · 2013-11-11Clinical Trial Update: Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder [Phase 3]
Phase 3 clinical trial evaluating the effects of adding aripiprazole to olanzapine in overweight patients with schizophrenia or schizoaffect…
-
CLINICAL_TRIALS trial_result · 2013-11-11Clinical Trial Update: Study of Alternate Formulation of Aripiprazole in Agitated Patients With Schizophrenic Disorders [Phase 2, Phase 3]
Trial update on an alternate formulation of aripiprazole for agitation in schizophrenia, covering Phase 2 and Phase 3 with the study status …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-11-11Clinical Trial Update: Study of Three Doses of Aripiprazole in Patients With Acute Schizophrenia [Phase 4]
A Phase 4 trial evaluated three dosing regimens of aripiprazole in adults with acute schizophrenia and has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: A Study of Aripiprazole in the Management of Patients With Schizophrenia in the General Psychiatric Practices [Phase 3]
A Phase 3 study evaluating aripiprazole for the management of schizophrenia in general psychiatric practice has completed, with results summ…
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: A Study of Aripiprazole in Patients With Schizophrenia in General Psychiatric Practices [Phase 3]
This Clinical Trial Update reports the completion of a Phase 3 study evaluating aripiprazole for schizophrenia and schizoaffective disorder …
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: Effect on Cognitive Function of a Treatment With Aripiprazole [Phase 4]
A Phase 4 trial evaluating the effect of aripiprazole on cognitive function in schizophrenia has been completed.
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: Comparative Study of Aripiprazole and Olanzapine in the Treatment of Patients With Acute Schizophrenia [Phase 3]
A Phase 3 clinical trial comparing aripiprazole and olanzapine for acute schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: A D2 Receptor Occupancy and fMRI Study in Schizophrenic Subjects Treated With Lurasidone [Phase 3]
A Phase 3 imaging study evaluating D2 receptor occupancy and fMRI brain responses in schizophrenia patients treated with lurasidone has comp…
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: A Study of Adjunctive Treatment of Aripiprazole in Schizophrenic Patients [Phase 4]
A Phase 4 study evaluating adjunctive aripiprazole in schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: Aripiprazole Oral Acceptability Trial [Phase 3]
A Phase 3 trial evaluating the oral acceptability of aripiprazole in schizophrenia has been completed.
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: Treatment Response to Rehabilitation in Patients With Schizophrenia [NA]
The clinical trial evaluating rehabilitation to improve treatment response in schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: Schizophrenia Trial of Aripiprazole [Phase 3]
Completed Phase 3 trial update of aripiprazole for schizophrenia.
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: Aripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder. [Phase 4]
A Phase 4 trial evaluated aripiprazole as dual therapy in chronic stable schizophrenia or schizoaffective disorder; the study has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: A Switch Study of BMS-337039 in Schizophrenic Out-patients [Phase 4]
This entry notes the completion of a Phase 4 switch study of BMS-337039 in outpatients with schizophrenia.
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: An Observational Study to Evaluate Efficacy and Safety of Risperidone Long-Acting Injection for Treatment of Schizophrenia
This document reports an observational study evaluating the efficacy and safety of risperidone long-acting injection for schizophrenia; the …
-
CLINICAL_TRIALS trial_result · 2013-11-04Clinical Trial Update: Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Negative Symptoms in Schizophrenia [NA]
A completed clinical trial evaluating repetitive transcranial magnetic stimulation (rTMS) for negative symptoms in schizophrenia.
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: Treatment on Iatrogenic Weight Gain and Dyslipidaemia Associated With Olanzapine [Phase 2]
Phase 2 clinical trial evaluating treatment for iatrogenic weight gain and dyslipidemia caused by olanzapine in schizophrenia. The study was…
-
CLINICAL_TRIALS trial_result · 2013-10-31Clinical Trial Update: Risperidone Augmentation in Patients With Schizophrenia [Phase 4]
A Phase 4 clinical trial evaluating risperidone augmentation in patients with schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2013-10-29Clinical Trial Update: GlyT-1 Inhibitor Treatment for Refractory Schizophrenia [Phase 2]
Phase 2 clinical trial update reporting completion of testing for a GlyT-1 inhibitor in treatment-refractory schizophrenia.
-
CLINICAL_TRIALS trial_result · 2013-10-25Clinical Trial Update: Augmenting Zyprexa With Naltrexone to Ameliorate Metabolic Side-Effects [Phase 1]
A Phase 1 trial testing whether adding naltrexone to olanzapine (Zyprexa) can reduce metabolic side effects in people with schizophrenia or …
-
CLINICAL_TRIALS trial_result · 2013-10-23Clinical Trial Update: Efficacy and Safety of Aripiprazole in Patients With Schizophrenia or Bipolar Disorder
An update on the efficacy and safety of aripiprazole in patients with schizophrenia or bipolar disorder from a completed clinical trial.
-
CLINICAL_TRIALS trial_result · 2013-10-10Clinical Trial Update: A Phase 4 Study to Evaluate Response to Treatment and Safety of Paliperidone Extended-Release in Participants With Schizophrenia [Phase 4]
Phase 4 trial evaluating the response to treatment and safety of Paliperidone Extended-Release in schizophrenia has completed.